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Abstract
It remains unknown whether obese individuals with more components of the metabolic syndrome 
and/or prediabetes demonstrate altered activation of brain centers in response to food cues. We 
examined obese prediabetics (n=26) vs. obese nondiabetics (n=11) using fMRI. We also 
performed regression analyses on the basis of the number of MetS components per subject. Obese 
individuals with prediabetes have decreased activation of the reward-related putamen in the fasting 
state and decreased activation of the salience- and reward-related insula after eating. Obese 
individuals with more components of MetS demonstrate decreased activation of the putamen while 
fasting. All these activations remain significant when corrected for BMI, waist circumference 
(WC), HbA1c and gender. Decreased activation in reward-related brain areas between obese 
individuals is more pronounced in subjects with prediabetes and MetS. Prospective studies are 
needed to quantify their contributions to the development of prediabetes/MetS and to study 
whether these conditions may predispose to the exacerbation of obesity and the development of 
comorbidities over time.
Obesity and its comorbidities are rapidly growing global concerns1, 2. Although many 
studies have observed changes on functional brain activity in obese versus lean individuals 
which would predispose obese subjects to overeating3, 4, it remains unknown whether such 
changes would be more pronounced among subjects who have MetS and/or prediabetes.
Therefore, we examined cross-sectionally using fMRI how neural responses to food cues 
differ between 1) obese individuals with prediabetes vs. obese individuals without 
prediabetes; and 2) obese individuals meeting the definition of MetS. We elected to use 
individuals with prediabetes, but not overt type 2 diabetes, in order to prevent differences 
due to extremes of blood sugar levels from glycosuria or to changes in body weight due to 
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diabetes itself or diabetes medications. We hypothesized that changes would be in reward- or 
saliency- related brain areas.
Methods
Thirty-six men and women provided written informed consent to participate in this study, 
approved by the BIDMC IRB and selected as per previous9. Participants had an overnight 
visit, which consisted of at least a 12 hours fast followed by 2 fMRI scans, one in the fasting 
and another in the fed state. The standardized meal consisted of a turkey sandwich, piece of 
fruit, pretzels, and a bottle of water (630kcal; 22.2gfat; 73.8gcarbohydrates; 31.5gprotein). 
Prediabetes was defined as HbA1c=5.7–6.4%5. Metabolic syndrome criteria were defined 
according to the NIH standards of 1) waist circumference of >35 inches for women or >40 
inches for men; 2) triglyceride levels of 150 mg/dL or higher (or being on medicine to treat 
high triglycerides); 3) HDL cholesterol levels of <50 mg/dL for women or <40 mg/dL for 
men (or being on medication for low HDL); 4) Blood pressure of 130/85mmHg (or being on 
medication to treat high blood pressure); and/or 5) Fasting blood sugar level >126 mg/dL.
fMRI protocol
Participants viewed food and non-food items within a GE 3T MRI scanner at BIDMC in 
both the fasting and fed states and were analyzed as per previous6–9. EPIBOLD parameters: 
TR=3.5s, TE=25ms, resolution=2.5×2.5mm, matrix=96×96, FOV=24×24cm, 
bandwidth=83.33kHz, slice thickness=3mm. The contrast images [highly desirable>less 
desirable food images and all food (both highly and less desirable food cues)>non-food 
images] of the first-level analysis were used for the second-level group statistics. To 
compare prediabetics and nondiabetics, two sample t-tests were used. To compare across 
MetS criteria, regressions were performed. In a subsequent analysis, t-tests were performed 
for subjects meeting each of the MetS criteria (e.g. categories of yes/no for TG>50). BMI, 
waist circumference(WC), gender, and HbA1c were included as covariates in secondary 
analyses. We then utilized small volume corrections (SVC) on the resultant fMR images for 
the areas of interest as previously described in order to be able to compare our results to 
those which were previously found10. Briefly, spherical regions of interest were created in 
marsbar with radii 5-mm (for amygdala) or 10-mm (for insula, putamen, and OFC) for SVC, 
and results which passed p<.05, FWE corrected for peak are reported.
Results
Obese prediabetics vs. obese nondiabetics
There were no differences in anthropometry between obese prediabetics (n=26) and 
nondiabetics (n=11; Table 1). While fasting, prediabetics showed decreased activations in 
the posterior putamen to highly versus less desirable food cues (Supplemental Table S1; 
Figure 1a). After a meal, prediabetics show decreased activations to food>non-food cues in 
the insula (Supplemental Table S1; Figure 1b). These activations remain significant with 
corrections for BMI, WC, HbA1c, and gender.
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Differences in relation to number of MetS components
Of our study sample, 11 met one criterion for MetS, 14 met two criteria for MetS, 12 met 
three criteria for MetS, and 1 met four criteria for MetS. Between the groups, there were no 
differences in anthropometric characteristics (Table 1). Systolic blood pressure (p<.001) and 
HbA1c levels (p<.05) were different between the groups (Table 1). While fasting, 
participants who met more MetS criteria showed less activation in the posterior putamen to 
highly>less desirable food cues (Supplemental Table S1; Figure 1c), which survives when 
corrected for covariates. After a meal, participants who met more MetS criteria showed 
greater activation of the amygdala and caudate to all food>non-food cues (Supplemental 
Table S1; Figure 1d). The activation in the caudate survives correction for covariates; 
however, the activation in the amygdala survives correction for BMI or WC, but not for 
HbA1c or gender.
Of the individual components of MetS, all patients met the component for WC, 17 met the 
component for TG, 11 met the component for HDL, 11 met the component for BP, and none 
met for blood glucose. There were no differences between participants who met or did not 
meet each criterion, except that individuals who met the MetS criterion for TG had 
decreased activation in the insula to highly desirable>less desirable food cues in the fasting 
state (data not shown; 431mm3; p<.003, FWE-corrected; X,Y,Z: −34,12,0).
Discussion
Differences between obese individuals with and without prediabetes
Obese prediabetics show less reward-related activations in the insula and putamen to highly 
desirable food cues while fasting which persists after a meal where they demonstrate 
decreased activation of the insula to all food cues. The putamen is involved in the reward 
system and responds to the rewarding value of food cues11, 12. Activations of the putamen 
have also been shown to predict future weight gain12. Together, this suggests that obese 
individuals with prediabetes have a decreased reward-related response to food cues as 
compared to their obese counterparts without prediabetes. This may be underlying their 
predisposition to developing obesity and future insulin resistance, as hypoactivation of the 
reward system has been repeatedly implicated in obesity in general, and obese individuals 
repeatedly show altered reward responses to food cues4, 13, 14. This hypoactivation of the 
reward system is thought to lead to obesity by leading individuals to seek more rewarding 
food. Considering these findings remain when controlled for BMI, HbA1c, WC, and gender, 
hypoactivation of reward centers is likely causal and not secondary to the development of 
prediabetes. As such, it would predispose to the relative worsening of obesity and 
development of comorbidities later in life.
Differences amongst obese individuals with components of MetS
Individuals with more components of MetS demonstrate less reward-related putamen 
activation in the fasting state, but more postprandial caudate and amygdala activations to 
food cues. However, the latter becomes non-significant after adjusting for confounders such 
as HbA1c and gender. Similar to the putamen, the caudate is involved in evaluating the 
rewarding value of food cues15–17 and activation of the caudate is linked to future weight 
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gain16. One theory of reward and obesity is that obese individuals have less reward-related 
responses to food cues which makes them seek more and more high calorie/fat foods. This is 
supported by positron emission tomography findings of deficits in the striatal dopaminergic 
system18–20. The observations in participants meeting more MetS components indicate a 
hypoactivation of the reward system in these individuals while fasting which leads them to 
seek more food then those with less MetS. Similar to findings in prediabetes, this decreased 
activation persists with corrections for HbA1c, gender, WC, and BMI, suggesting it might be 
causal for the worsening of both obesity and the comorbidities of obesity/MetS. After a 
meal, individuals meeting more MetS components show increased activation of the caudate 
and emotion- and salience-related amygdala, which may suggest that these individuals have 
a heightened reward response after consuming food. Since the activation of the amygdala 
disappears after controlling for HbA1c, this increase in response is likely secondary to MetS 
components, such as increased blood sugar or blood pressure compounded by a recent meal. 
Furthermore, as we do not see significant changes by particular MetS criterion met, we can 
assume that these changes are cumulative by the number of MetS criteria met and not by the 
particular criterion, but this will need to be confirmed with larger samples.
Conclusions, strengths and limitations
Altogether, we observed changes in the central nervous system processing of food cues with 
comorbidities of obesity. Our findings suggest that an exaggerated hypoactivation of the 
reward system before a meal, which leads individuals to seek more rewarding foods, occurs 
with, and possibly causes, additional comorbidities of obesity, e.g. MetS components and 
prediabetes. Strengths of the study include the state-of-the-art methodology used and 
blinding of investigators to MetS and prediabetes status during assessments. We are limited 
by the number of subjects and lower severity of comorbidities in our preliminary sample. 
Although there was not diabetes per se in this initial study, this allows us to rule out the 
effects of anti-diabetic drugs or outright glycosuria or extreme insulin resistance on brain 
activations. Additionally, the number of subjects is limited, albeit sufficient to demonstrate 
significance, and we do not have a normal weight, healthy population for direct comparison, 
which should be done in future studies. Prospective studies are needed to quantify whether 
this may contribute to the development of prediabetes/MetS, and if positive, these areas 
could serve as targets for early intervention and therapy. Our findings should be confirmed 
by larger and prospective studies and extended to type 2 diabetes.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Results from small volume correction (SVC) analysis of obese prediabetics vs. nondiabetics 
in the fasting (A) and fed (B) states and with the number of MetS criteria met in the fasting 
(C) and fed (D) states (see Supplemental Table 2). Areas significant at p<.05, FWE 
corrected for multiple comparisons are circled in red. The y-axis represents effect size of the 
activation (z scores). BOLD contrasts are superimposed on a T1 structural image in 
neurological orientation. The color bar represents voxel T value.
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